Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial

Nicholas J. Short, Hagop M. Kantarjian, Sanam Loghavi, Xuelin Huang, Wei Qiao, Gautam Borthakur, Tapan M. Kadia, Naval Daver, Maro Ohanian, Courtney D. Dinardo, Zeev Estrov, Rashmi Kanagal-Shamanna, Abhishek Maiti, Christopher B. Benton, Prithviraj Bose, Yesid Alvarado, Elias Jabbour, Steven M. Kornblau, Naveen Pemmaraju, Nitin JainYvonne Gasior, Mary Ann Richie, Sherry Pierce, Jorge Cortes, Marina Konopleva, Guillermo Garcia-Manero, Farhad Ravandi

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences